Friday, 27 September 2019

Gastroesophageal Reflux Disease Market Growth Study 2019: Key Players are AstraZeneca, ADDEX THERAPEUTICS, MediGus Ltd., EndoGastric Solutions


Gastroesophageal reflux disease is a digestive condition which usually occurs when the acid of the stomach flows back to the tube which connects stomach and mouth. This usually causes acid indigestion and heartburn. In simple words, gastroesophageal reflux takes the stomach acid back into the esophagus. Global gastroesophageal reflux disease market is set to witness a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. Top Manufacturers Covered in the Report: AstraZeneca, ADDEX THERAPEUTICS, MediGus Ltd., EndoGastric Solutions, Inc., Eisai Co., Ltd., Takeda Pharmaceutical Company Limited., Medical Devices Business Services, Inc, Pfizer Inc., Cigna, EndoStim, Inc., Ironwood Pharmaceuticals, Inc., Hamilton Health Care System, Boston Scientific Corporation, Zydus Cadila, Gimv, Medtronic, and others.


Segmentation: Global Gastroesophageal Reflux Disease Market

·         Global Gastroesophageal Reflux Disease Market By Drug Type (Antacids, H2 Receptor Blockers, Proton Pump Inhibitors, Pro- Kinetic Agents)
·         Devices (Digitrapper, Bravo System, Stretta, Linx Reflux Management System, MUSE System, Other Devices)
·         Route of Administration (Oral, Parenteral)
·         Dosage Form (Solid, Liquid)
·         Product Type (Diagnostic Devices, Manometry System, PH Monitoring System, Esophagoscopes and Gastroscopes, Treatment Devices, Ultrasonic Surgical Endostapler, Fundoplication Devices, Sphincter Augmentation Devices, Radiofrequency Ablation Devices)
·         Procedure Type (Diagnostic Procedure, Fundoplication Procedure, Radiofrequency Thermal Ablation, Magnetic Sphincter Augmentation)
·         Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026


Focus of the report

·         CAGR values in the market for the forecast period
·         Key trends in the market place
·         Major players and brands
·         Historical and current market size and projection up to 2026.
·         Detailed overview of parent market
·         Changing market dynamics of the industry


Market Drivers

·         Increasing awareness about GERD will drive the market  growth
·         Growing trend for self-medication is also driving this market growth
·         Expansion in geriatric population will also act as a driver for this market
·         Rising preference for minimally invasive procedures will also propel the market growth

Market Restraints

·         Challenge associated with the expiration of patent protected therapeutics will restrain the market growth
·         Poor drug pipeline developments is another factor restraining the market growth

Competitive Analysis:

Global gastroesophageal reflux disease market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of gastroesophageal reflux disease market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

·         Current and future of global gastroesophageal reflux disease market outlook in the developed and emerging markets
·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period
·         The latest developments, market shares, and strategies that are employed by the major market players

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818

Related Report-




Thursday, 26 September 2019

Healthcare Chatbots Market: Moving Towards Brighter Future| HealthTap, Inc., Anboto, Sensely, Buoy Health, Inc., Infermedica, Babylon, Baidu, Inc.


A chatbot can be defined as an interactive application that utilizes the artificial intelligence and a set of rules to interact with humans using the textual conversation process. It assists the users in various sectors. Healthcare sector has been an attractive industry for the companies developing chatbot applications for clinicians and patients. The global healthcare chatbots market is expected to rise from its initial estimated value of USD 122.0 million in 2018 to an estimated value of USD 542.3 million by 2026 registering a CAGR of 20.5% in the forecast period of 2019-2026. Key players profiled in this report are: HealthTap, Inc., Anboto, Sensely, Buoy Health, Inc., Infermedica, Babylon, Baidu, Inc., Ada Health GmbH, PACT Care BV, Woebot, GYANT.COM, Inc., Creative Virtual, Your.MD, Synthetix Ltd., Next IT Corp., CX Company, Inbenta Technologies Inc., eGain, Nuance Communications, Inc. and eCreations.


Segmentation: Global Healthcare Chatbots Market

·         Global Healthcare Chatbots Market By Component (Software, Service)
·         Deployment Model (On-premise Model, Cloud-based Model)
·         Application (Diagnosis & medical aid, Appointment scheduling)
·         End-User (Patients, Healthcare Providers, Insurance Companies, Others)
·         Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026


Competitive Analysis: Global Healthcare Chatbots Market
The global healthcare chatbots market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of healthcare chatbots market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.


Market Drivers:

·         Rising demand for virtual health assistance is a major factor leading to industry growth
·         Constant innovations and technological developments in the industry will act as a major market driver

Market Restraints:

·         Increasing concerns related to data privacy is acting as a major restraint for the market
·         Lack of knowledge for chatbot development will also hamper the market demand

Key Developments in the Market:

·         In June, 2018, Bupa entered into a strategic partnership with Babylon to offer artificial intelligence powered health services to its corporate clients. This strategy would help the company to enhance its customer base.

·         In July, 2017, Baidu acquired Kitt.ai to provide developers a platform for building chatbots based on NLP and AI technology. This would help in the development of the company and also would expand their customer base

Reasons to Purchase this Report:

·         Current and future of global healthcare chatbots market outlook in the developed and emerging markets
·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period
·         The latest developments, market shares, and strategies that are employed by the major market players

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818

Related Report-




Tuesday, 24 September 2019

Pharmaceutical Analytical Testing Outsourcing Market: Moving Towards Brighter Future| SGS SA; TOXIKON; Eurofins Scientific; Pace Analytical Services, LLC; Intertek Group plc


Pharmaceutical analytical testing outsourcing is the constitution of services from the manufacturing, testing and validating the pharmaceuticals and therapeutics. This involves validating pharmaceutical ingredient, compounds, manufacturing methods required for the development of these drugs. Global pharmaceutical analytical testing outsourcing market is expected to rise to an estimated value of USD 10.42 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. Key players profiled in this report are: SGS SA; TOXIKON; Eurofins Scientific; Pace Analytical Services, LLC; Intertek Group plc; Pharmaceutical Product Development, LLC; Exova; Charles River; Boston Analytical; West Pharmaceutical Services, Inc.; Dalton Pharma Services; Merck KGaA; Cambrex Corporation; WuXi AppTec; Source BioScience; Ajinomoto Bio-Pharma; Catalent, Inc; Gateway Analytical


Segmentation: Global Pharmaceutical Analytical Testing Outsourcing Market

·         Global Pharmaceutical Analytical Testing Outsourcing Market By Service Type (Bioanalytical Testing, Method Development & Validation, Stability Testing, Others)
·         Product Type (Raw Materials, Finished Product, Active Pharmaceutical Ingredients),
·         End-Users (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Industry)
·         Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026


Competitive Analysis: Global Pharmaceutical Analytical Testing Outsourcing Market

Global pharmaceutical analytical testing outsourcing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of pharmaceutical analytical testing outsourcing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.


Market Drivers

·         Increasing usage of pharmaceuticals and therapeutics requiring specialized manufacturing capabilities; this factor is expected to drive the growth of the market
·         Growth in modernization and innovations requiring reduction of operating costs of manufacturing and development; this factor is expected to enhance the growth of the market
·         Presence of strict regulations and requirement of pertaining to the standards provided by the authorities; this factor is expected to flourish the growth of the market

Market Restraints

·         Reliance on performance of unstable outsourced manufacturing organizations; this factor is expected to hamper the market growth
·         Concerns regarding privacy/theft of confidential data of manufacturing pharmaceuticals; this factor is expected to restrain the market growth

Reasons to Purchase this Report

·         Current and future of global pharmaceutical analytical testing outsourcing market outlook in the developed and emerging markets
·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period
·         The latest developments, market shares, and strategies that are employed by the major market players


About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818

Related Reports:



Thursday, 19 September 2019

Nuclear Medicine Equipment Market: Moving Towards Brighter Future| Philips Healthcare, GE Healthcare, Cardinal Health Inc.


The Global Nuclear Medicine Equipment Market accounted to USD 1.7 billion in 2016 growing at a CAGR of 6.2% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Some of the leading key players profiled in this study: CMR Naviscan, SurgicEye GmbH, Mallinckrodt, Neusoft Corporation, DDD-Diagnostic A/S, CANON MEDICAL SYSTEMS CORPORATION, Mediso Ltd, Digirad Corporation., Siemens, Cardinal Health., GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Bozlu Holding, Compañía Mexicana de Radiología CRG, SA de CV, Neusoft Corporation, TOSHIBA CORPORATION, Bartec Technologies Ltd., Biodex, Cyclopharm


Global Nuclear Medicine Equipment Market - Major Market Drivers and Restraints:

·         Increasing incidences and prevalence of diseases such as cancer
·         Technological advancements in medical imaging devices
·         Government initiatives in modernizing diagnostic imaging centers
·         High cost of nuclear imaging equipment
·         Shorter half-life of radiopharmaceuticals


Focus of the report

  • CAGR values in the market for the forecast period
  • Key trends in the market place
  • Major players and brands
  • Historical and current market size and projection up to 2026.
  • Detailed overview of parent market
  • Changing market dynamics of the industry

Global Nuclear Medicine Equipment Market - Market Segmentation:

·         By product, the market for nuclear medicine equipment market is segmented into single-photon emission computed tomography (SPECT), planar scintigraphy, hybrid pet. The single-photon emission computed tomography (SPECT) segment is further sub-segmented into standalone, and hybrid.
·         By application, the market for nuclear medicine equipment market is segmented into oncology, cardiology, neurology, and others.
·         On the basis of end-user, the nuclear medicine equipment market is segmented into hospitals, imaging centers, academic & research centers.
·         By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa)
Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Reasons to Purchase this Report
                    Current and future of Global Nuclear Medicine Equipment Market outlook in the developed and emerging markets
                    The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
                    Regions/Countries that are expected to witness the fastest growth rates during the forecast period
                    The latest developments, market shares, and strategies that are employed by the major market players


About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818

Wednesday, 18 September 2019

Oncology Nutrition Market Sees Promising Growth| Danone, Nestle, B, Braun Melsungen AG, Abbott


The Global Oncology Nutrition Market is expected to reach USD 2.6 billion by 2025, from USD 1.34 billion in 2017 growing at a CAGR of 5.6 % during the forecast period of 2018 to 2025. Some of the leading key players profiled in this study: Danone, Nestle, B, Braun Melsungen AG, Abbott, Fresenius Kabi AG, Mead Johnson & Company, LLC. , Meiji Holdings Co., Ltd., Hormel Foods Corporation, Global Health Products, Inc., Victus, Lactonova 


Market Segmentation: Global Oncology Nutrition Market

·         The global oncology nutrition market is segmented based on cancer or end user type and by geographical segments.
·         Based on cancer type, the market is segmented into head & neck cancer, stomach & gastrointestinal cancer, liver cancer, pancreatic cancer, esophageal cancer, lung cancer, breast cancer, blood cancer
·         Based on geography, the market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.


Competitive Analysis: Global Oncology Nutrition Market

The global oncology nutrition market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes global oncology nutrition market for global, Europe, North America, Asia Pacific and South America

Get 20% Discount On Report Offer Wailed Up to Limited Period @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-oncology-nutrition-market

Major Market Drivers and Restraints:

·         Rising prevalence rate of cancer
·         Increasing number of patients being treated for malnutrition
·         increasing quality of clinical research on nutritional interventions
·         Rising demand for nutritional feeding in the homecare sector
·         shifting focus from parenteral to enteral nutrition

Oncology Nutrition Market report provides complete background analysis of the Healthcare IT industry which includes an assessment of the parental market. By thinking from customer point of view, a team of researchers, analysts and industry experts work carefully to generate this Oncology Nutrition Market research report. A high quality global market research is brought together for the success of your business at international level.

Reasons to Purchase this Report

·         Current and future of global Oncology Nutrition Market outlook in the developed and emerging markets
·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period
·         The latest developments, market shares, and strategies that are employed by the major market players

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818


Human Insulin Drugs and Delivery Devices Market to witness Massive CAGR Growth By 2026 | Novo Nordisk A/S, Eli Lilly and Company


Global Human Insulin Drugs and Delivery Devices Market is set to rise from its initial estimated value of USD 33.78 billion in 2018 to an estimated value of USD 61.38 billion by 2026, registering a CAGR of 7.75% in the forecast period of 2019-2026. Some of the leading key players profiled in this study Novo Nordisk A/S, Eli Lilly and Company, Sanofi, B. Braun Melsungen AG, BD, Biocon, Albireo Pharma Inc., Julphar, WOCKHARDT, CeQur SA, Ypsomed, AstraZeneca, Boehringer Ingelheim International GmbH, Johnson & Johnson Services Inc., Novartis AG, Takeda Pharmaceutical Company Limited, Bayer AG, and Merck & Co. Inc.

Segmentation: Global Human Insulin Drugs and Delivery Devices Market

  • Global Human Insulin Drugs and Delivery Devices Market, By Product (HI Drugs, HI Delivery Devices)
  • Drugs (Insulin Analogs & Biosimilar, HI Biologics), Delivery Device (Syringes, Pens, Pen Needles)
  • Application (Type I Diabetes, Type II Diabetes)
  •  Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026    


Focus of the report

·         CAGR values in the market for the forecast period
·         Key trends in the market place
·         Major players and brands
·         Historical and current market size and projection up to 2026.
·         Detailed overview of parent market
·         Changing market dynamics of the industry


Market Drivers:

·         High cases and increasing amount of diabetic patients worldwide is expected to drive the market growth
·         Advancements in the market and reimbursements procedures in developed regions is also expected to drive the market growth

Market Restraints:

·         Stringent regulations and reforms for the approval of products is also expected to restrain the market growth
·         High cost of manufacturing delivery devices is also expected to act as a restraint to the market growth

Competitive Analysis:

Global human insulin drugs and delivery devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of human insulin drugs and delivery devices market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report:

·         Current and future of global human insulin drugs and delivery devices market outlook in the developed and emerging markets
·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period
·         The latest developments, market shares, and strategies that are employed by the major market players


About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818